82 Biggest Movers From Yesterday
Gainers
Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tuesday.
HC Wainwright & Co. Downgrades Clovis Oncology to Neutral
HC Wainwright & Co. analyst Edward White downgrades Clovis Oncology (NASDAQ:CLVS) from Buy to Neutral.
HC Wainwright & Co. Maintains Buy on Clovis Oncology, Lowers Price Target to $4
HC Wainwright & Co. analyst Edward White maintains Clovis Oncology (NASDAQ:CLVS) with a Buy and lowers the price target from $5 to $4.
81 Biggest Movers From Yesterday
Gainers
Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday.
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Clovis Oncology Q1 2022 Earnings Conference Call On May 4, 2022 At 08:30 AM ET
Clovis Oncology (NASDAQ:CLVS) will host a conference call at 08:30 AM ET on May 4, 2022, to discuss Q1 2022 earnings results.
How to Attend Clovis Oncology (CLVS) Conference Call
Follow this link to access the live webcast.
Clovis Oncology Targeted Cancer Radiation Therapy Shows Greater Tumor Inhibition
Clovis Oncology Inc (NASDAQ: CLVS) announced two abstracts featuring
35 Stocks Moving In Monday’s Mid-Day Session
Gainers
Aterian, Inc. (NASDAQ: ATER) shares jumped 43.5% to $3.3457. Aterian said Cynthia Williams has joined the Company's Board of Directors.